InvasiCell, a cutting-edge medical technology developed by Adonis Hadjigeorgiou and team at the University of Cyprus, has wowed attendees at the Tahko Ski Lift Pitch event in Finland. This innovative device replicates the complex environment of tumors, allowing for groundbreaking insights into cancer cell behavior and drug efficacy, revolutionizing cancer research and treatment.
What is InvasiCell and how does it contribute to cancer research?
InvasiCell is an advanced medical technology developed at the University of Cyprus by Adonis Hadjigeorgiou and his team that replicates the complex microenvironment of malignant tumors. It enables researchers to closely observe cancer cell behavior, including proliferation and metastasis, and test the efficacy of drugs, thereby revolutionizing cancer research, diagnosis, and treatment.
Innovative Cancer Research Technology
Adonis Hadjigeorgiou, a talented doctoral student from the University of Cyprus, recently took the stage at the Tahko Ski Lift Pitch event in the picturesque city of Kuopio, Finland. His presentation featured an advanced medical technology known as InvasiCell. Professor Paris Skourides, a notable figure in the Department of Biological Sciences at the University of Cyprus, helms the laboratory where this groundbreaking research takes place. InvasiCell represents a significant leap forward, as it can replicate the intricate microenvironment of malignant tumors.
InvasiCell caught the attention of potential investors, mentors, and fellow scientists due to its profound implications for cancer research, diagnosis, and treatment. The technology’s ability to mimic tumor conditions allows researchers to observe cancer cell proliferation and metastasis closely, as well as to test the efficacy of various drugs on these processes.
The Path to Innovation and Entrepreneurship
The journey to Finland was more than an individual endeavor for Hadjigeorgiou. It was a collaborative effort, supported by the Innovation Management Division at the University of Cyprus, which is part of the Young Universities for the Future of Europe (YUFE) Alliance. This alliance underscores the university’s dedication to promoting a culture of innovation and entrepreneurship.
Hadjigeorgiou’s proposal, accompanied by other pioneering startups and research projects from YUFE-associated institutions, was meticulously selected from a pool of over 60 applications. The selection process was conducted by a dedicated YUFE committee and the organizers of the Tahko Ski Lift Pitch. This unique event, now in its eighth year, transcends the bounds of conventional conferences, offering a dynamic setting for entrepreneurs to pitch their ideas against a stunning backdrop of snow-covered mountains.
A Team Effort and International Recognition
The creation of InvasiCell is a testament to collaborative spirit and intellectual synergy. Alongside Hadjigeorgiou, Professor Paris Skourides and postdoctoral researcher Neophytos Christodoulou share the credit as co-inventors of this promising technology, which is currently in the process of international patent registration.
The university’s announcement proudly highlights the device’s potential to revolutionize our understanding of cancer progression by identifying changes that drive growth and metastasis. These insights are crucial for pinpointing new therapeutic targets and enhancing prognostic and diagnostic accuracy in the ongoing battle against cancer.
Supporting the Future of Medical Innovation
The research team’s efforts and the development of InvasiCell have been made possible through funding from various sources, including the University of Cyprus and Cyprus Seeds. Moreover, the university’s Innovation Support Division is actively assisting in the patent registration and commercial exploitation of the technology. This division is tasked with managing and promoting the use of valuable intellectual property developed within the university. Since mid-2022, there has been a concerted push to harness this intellectual capital, reflecting a broader commitment to research that can make a real-world impact.
What is InvasiCell and how does it contribute to cancer research?
InvasiCell is an advanced medical technology developed at the University of Cyprus by Adonis Hadjigeorgiou and his team that replicates the complex microenvironment of malignant tumors. It enables researchers to closely observe cancer cell behavior, including proliferation and metastasis, and test the efficacy of drugs, thereby revolutionizing cancer research, diagnosis, and treatment.
Who are the key figures behind the development of InvasiCell?
The development of InvasiCell was led by Adonis Hadjigeorgiou, a talented doctoral student, in collaboration with Professor Paris Skourides and postdoctoral researcher Neophytos Christodoulou. They are the co-inventors of this innovative medical technology that has the potential to revolutionize cancer research and treatment.
How was InvasiCell received at the Tahko Ski Lift Pitch event in Finland?
InvasiCell impressed attendees at the Tahko Ski Lift Pitch event in Finland, garnering attention from potential investors, mentors, and fellow scientists. The technology’s ability to replicate tumor conditions and provide insights into cancer cell behavior and drug efficacy was well-received, highlighting its significance in advancing cancer research.
How is the University of Cyprus supporting the development and commercialization of InvasiCell?
The University of Cyprus has been actively supporting the development and commercialization of InvasiCell through funding from various sources, including Cyprus Seeds. The university’s Innovation Support Division is assisting in the patent registration and commercial exploitation of the technology, reflecting a commitment to promoting medical innovation with real-world impact.
